Moleac is pleased to announce that NeuroAiD™II has been awarded Gold accreditation by Empowered By Evidence.
Moleac is pleased to announce that NeuroAiD™II has been awarded Gold accreditation by Empowered By Evidence. SINGAPORE, February 5, 2026 – Moleac Moleac is pleased to announce that NeuroAiD™II has been awarded Gold accreditation by Empowered By Evidence. This...
How to Support a Person with Alzheimer’s Disease?
How to Support a Person with Alzheimer’s Disease? Alzheimer’s disease is a neurodegenerative condition that affects not only the persons who are diagnosed but also their entire families, especially those who take on the role of caregiver. When a mother or father...
Advancing Post-Stroke Care: Moleac at the J.P. Morgan Healthcare Conference
Advancing Post-Stroke Care: Moleac at the J.P. Morgan Healthcare Conference We’re pleased to share that David Picard, CEO of Moleac, was recently interviewed at the J.P. Morgan Healthcare Conference in San Francisco. In the interview, David discusses unmet needs in...
